Article
Inhibitors of cell cycle checkpoint target Wee1 kinase – a patent review (2003–2022)
2 Dec 2022
Abstract excerpt
INTRODUCTION: DNA damage repair in most malignancies with mutation of p53 is more dependent on the G2/M checkpoint. Wee1 kinase is a key regulator of the G2/M checkpoint. If Wee1 is inhibited, it results in cells with unrepaired DNA damage entering mitosis prematurely, leading to mitotic catastrophe and subsequent cell death via the apoptotic program. Therefore, inhibition of Wee1 kinase which overexpressed in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
